Safety and Tolerability, PK, and PD Study of Single and Multiple ALXN2080 Doses in Healthy Participants

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2022
This study is designed to evaluate the safety and tolerability, pharmacokinetics and pharmacodynamics of single and multiple doses of ALXN2080 in healthy adult participants.
Epistemonikos ID: 62278a88638d2ae72548006de7d3dd14104e96e8
First added on: May 13, 2024